Archived Articles

Interactions among academia, healthcare providers, and industry


Newspapers/Magazines/Government Announcements

"Side Effects May Include Lawsuits - Dept of Justice Statements on the Five Major Companies Selling Anti-Psychotic Drugs" New York Times, 10/2/2010

"Harvard puts tighter limits on medical faculty" Boston Globe, 7/21/2010

"Private Money, Public Disclosure" Science Magazine, 7/3/2009

"Bitter Pill" Rolling Stone Magazine, 2/5/2009

"Prosecutors Plan Crackdown on Doctors who Accept Kickbacks "
New York Times, 3/4/2009

"Pfizer CME Grant Announcement"

"Medical Journal Rebukes Researcher." The Wall Street Journal, 9/12/2008

"Free drug samples cost more in the long run.", 3/25/2008

"Two former Amgen salespeople allege improper drug marketing." Los Angeles Times 1/9/08

"No Pharma Funding.", 1/1/08

"UMass policy limits doctor, drug maker ties." The Boston Globe, 12/24/07

"Dr. Drug Rep." New York Times 11/25/07

"Are doctors getting fees or 'bribes'? Artificial knee and hip makers settle accusations with Justice Dept." Pittsburgh Post-Gazette, 11/07/07

"Thanks, But No Thanks. Why more doctors, medical schools and hospitals are just saying no to drug-company promotions. Newsweek, 10/29/07

"Minnesota Limit on Gifts to Doctors May Catch On." New York Times, 10/12/07

"Doctor, just a little something for you. Complex sales strategies go way beyond freebies." Los Angeles Times, 8/6/07

"Lawmaker Call for Registry of Drug Firms Paying Doctors." New York Times, 8/3/07

"No easy cure: UPMC offers a smart policy on drug-firm ethics." (Editorial) Pittsburgh Post-Gazette, 7/8/2007

"Free Drug Samples?" New York Times, 5/1/07

"Court Strikes Law." New York Times, 5/1/07

"Doctors and Drug makers: A Move to End Cozy Ties." New York Times, 2/12/07


Policy initiatives:

"Final Report of the AAMC-AAU Task Force on Industry Funding of Medical Education.", 6/18/08

"Med School bans pharmaceutical freebies." Stanford Daily, 10/2/06

"U-M Health System: Drug samples, drug reps and beyond." 12/14/06

"Use of Educational Grants by Pharmaceutical Manufacturers." Prepared by the staff of the Committee on Finance, United States Senate, 4/07

"Senate Bill Would Require Drug Companies to Report All Gifts to Doctors." Chronicle of Higher Education, 9/10/07


Professional journals:

"Free Drug Samples Help Wealthy Patients More Than the Needy, Study Finds" American Journal of Public Health, February 2008, Vol 98, No. 2

"Doctors and Drug Companies — Scrutinizing Influential Relationships." New England Journal of Medicine Volume 357:1796-1797, 11/1/2007 Number 18

"Physicians and Drug Representatives: Exploring the Dynamics of the Relationship." Journal of General Internal Medicine, 2/07

"Following the Script: How Drug Reps Make Friends and Influence Doctors." PLoS Medicine, 4/07

"Characteristics and Impact of Drug Detailing for Gabapentin." PLoS Medicine, 4/07

"Sunshine Laws and the Pharmaceutical Industry." Journal of the American Medical Association 2007; 297:1255-1257. {Editorial in response to original article, "Pharmaceutical Company Payments to Physicians: Early Experiences With Disclosure Laws in Vermont and Minnesota"}

"A National Survey of Physician–Industry Relationships." New England Journal of Medicine, 4/26/07

"Ghost Management: How Much of the Medical Literature Is Shaped Behind the Scenes by the Pharmaceutical Industry?" PLoS Medicine Vol. 4, No. 9, e286 doi:10.1371/ journal.pmed.0040286 


Industry communications:

"More Than a Game of Keep Away." Pharmaceutical Executive, 5/1/06

"Selling to Hospitals: Through the Side Door." Pharmaceutical Representative, 7/1/06

"Access Restricted: Selling pharmaceuticals under the Physician Data Restriction Program." Pharmaceutical Representative, 2/1/07



No Free Lunch reading list